Blood typing has become a routine test item of clinical blood transfusion department and clinical laboratory, which includes ABO blood group, Rh blood group, and cross-matching of blood test.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

On June 26, 2021, Shanghai, Sanyou Biopharmaceutical (Shanghai) Co., Ltd. announced the closing of series B financing. This financing round was co-led by LH Ventures and Montesy Investment and followed by Grand Mount Capital and Seeking Capital (an existing investor).

Jun. 22, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector. The acquisition is expected to close during the third quarter of 2021.

On June 23, 2021, Suzhou Nanomicro Technology Co., Ltd. was listed on SSE STAR Market. Stock code: 688690. The number of A shares publicly issued this time is 44 million shares, the issue price is 8.07 yuan/share, and the opening price is 93.00 yuan/share.

On the evening of June 21st, Sansure acquired a 14.77% equity interest in GeneMind through equity transfer and subscription of newly added registered capital at a cost of RMB 255.2 million. When the transaction is completed, Sansure will become the second largest shareholder of GeneMind.

JP Morgan and Cowen said on Monday they have initiated coverage of shares of Singular Genomics Systems.JP Morgan gave the shares an Overweight rating and a price target of $30 while Cowen gave them an Outperform rating.

Roche announced recently that its RT-PCR-based Cobas SARS-CoV-2 nucleic acid test for use on the Cobas Liat system has received Emergency Use Authorization from the US Food and Drug Administration.

A new antibody testing study examining samples originally collected through the National Institutes of Health’s All of Us Research Program found evidence of SARS-CoV-2 infections in five states earlier than had initially been reported.

WASHINGTON, June 17, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced today that Danaher has entered into a definitive agreement to acquire privately held Aldevron, for a cash purchase price of approximately $9.6 billion.

Exponent announces that it has reached an agreement to sell BBI Group (“BBI”), a leading supplier of products and services to the global diagnostics and life sciences industries, to Novo Holdings A/S, a leading global life sciences investor, for an enterprise value of over ￡400 million.

On June 16, 2021, AVE Science & Technology Co. Ltd. was listed on the Sci-Tech innovation board. The number of A shares publicly issued this time is 17 million shares, the issue price is 14.71 yuan/share, the opening price is 38.24 yuan/share, and the maximum increase at the time of press is 207%.